| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 67.285.966 $ | 99,87 | 1.726.013 | |||||||
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 4.979.153 $ | 7,39 | 37.039 | |
| Vertex Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 4.969.484 $ | 7,38 | 11.104 | |
| Amgen Inc. | Amgen Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 4.786.796 $ | 7,10 | 14.213 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 3.424.325 $ | 5,08 | 5.570 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 2.147.078 $ | 3,19 | 7.110 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 1.673.068 $ | 2,48 | 10.624 | |
| Biogen Inc. | Biogen Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 1.542.128 $ | 2,29 | 7.868 | |
| Illumina, Inc. | Illumina, Inc. | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 1.335.783 $ | 1,98 | 8.197 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 1.308.527 $ | 1,94 | 2.350 | |
| Royalty Pharma PLC | Royalty Pharma PLC, Class A | EC | G7709Q104 | Long | Börsenkurs (Stufe 1) | 1.280.696 $ | 1,90 | 22.968 | |
| argenx SE | argenx SE, ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 1.271.541 $ | 1,89 | 1.521 | |
| Insmed Inc. | Insmed Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 1.235.452 $ | 1,83 | 11.556 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 1.150.716 $ | 1,71 | 38.370 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 1.032.119 $ | 1,53 | 10.669 | |
| Viatris Inc. | Viatris Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 1.003.697 $ | 1,49 | 61.728 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 999.154 $ | 1,48 | 21.173 | |
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 911.980 $ | 1,35 | 7.032 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 851.812 $ | 1,26 | 5.381 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 780.417 $ | 1,16 | 3.300 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | K08588103 | Long | Börsenkurs (Stufe 1) | 739.787 $ | 1,10 | 3.301 | |
| Summit Therapeutics Inc. | Summit Therapeutics Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 729.120 $ | 1,08 | 41.569 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 702.833 $ | 1,04 | 13.923 | |
| BridgeBio Pharma, Inc. | BridgeBio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 688.640 $ | 1,02 | 10.393 | |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 680.501 $ | 1,01 | 1.522 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 677.484 $ | 1,01 | 8.856 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 642.944 $ | 0,95 | 2.742 | |
| Madrigal Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 611.642 $ | 0,91 | 1.230 | |
| BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 590.717 $ | 0,88 | 10.311 | |
| BioNTech SE | BioNTech SE, ADR | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 586.446 $ | 0,87 | 6.112 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 584.870 $ | 0,87 | 7.507 | |
| Sanofi | Sanofi, ADR | EC | 80105N105 | Long | Börsenkurs (Stufe 1) | 573.038 $ | 0,85 | 13.122 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 522.505 $ | 0,78 | 1.493 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 506.386 $ | 0,75 | 6.597 | |
| BeOne Medicines Ltd. | BeOne Medicines Ltd., ADR | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 493.495 $ | 0,73 | 1.714 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 484.250 $ | 0,72 | 1.567 | |
| Tempus AI, Inc. | Tempus AI, Inc., Class A | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 470.078 $ | 0,70 | 9.314 | |
| Abivax S.A. | Abivax S.A., ADR | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 436.883 $ | 0,65 | 3.294 | |
| Nuvalent, Inc. | Nuvalent, Inc., Class A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 433.060 $ | 0,64 | 3.923 | |
| Halozyme Therapeutics, Inc. | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 420.999 $ | 0,62 | 6.327 | |
| ImmunityBio, Inc. | ImmunityBio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 414.495 $ | 0,62 | 55.119 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 396.602 $ | 0,59 | 7.716 | |
| Alkermes PLC | Alkermes PLC | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 376.925 $ | 0,56 | 8.934 | |
| Immunovant, Inc. | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 363.370 $ | 0,54 | 10.912 | |
| Kymera Therapeutics, Inc. | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 356.375 $ | 0,53 | 4.377 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 340.595 $ | 0,51 | 3.421 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 328.353 $ | 0,49 | 3.235 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 327.377 $ | 0,49 | 4.433 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 323.340 $ | 0,48 | 3.661 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 309.215 $ | 0,46 | 4.207 | |
| Cogent Biosciences, Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 304.222 $ | 0,45 | 8.702 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG | EC | H17182108 | Long | Börsenkurs (Stufe 1) | 288.540 $ | 0,43 | 5.136 | |
| CG Oncology, Inc. | CG Oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 281.987 $ | 0,42 | 4.527 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corp. | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 269.079 $ | 0,40 | 5.458 | |
| Centessa Pharmaceuticals PLC | Centessa Pharmaceuticals PLC, ADR | EC | 152309100 | Long | Börsenkurs (Stufe 1) | 254.504 $ | 0,38 | 6.401 | |
| Caris Life Sciences, Inc. | Caris Life Sciences, Inc. | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 252.322 $ | 0,37 | 15.091 | |
| Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 247.965 $ | 0,37 | 1.069 | |
| Xenon Pharmaceuticals Inc. | Xenon Pharmaceuticals Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 243.822 $ | 0,36 | 4.455 | |
| Indivior Pharmaceuticals, Inc. | Indivior Pharmaceuticals, Inc. | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 241.226 $ | 0,36 | 6.697 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 240.917 $ | 0,36 | 2.933 | |
| Travere Therapeutics, Inc. | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 233.399 $ | 0,35 | 4.947 | |
| Amneal Pharmaceuticals, Inc. | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 222.086 $ | 0,33 | 16.863 | |
| Twist Bioscience Corp. | Twist Bioscience Corp. | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 219.802 $ | 0,33 | 3.287 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 213.105 $ | 0,32 | 16.597 | |
| NewAmsterdam Pharma Co. N.V. | NewAmsterdam Pharma Co. N.V. | EC | N62509109 | Long | Börsenkurs (Stufe 1) | 207.839 $ | 0,31 | 6.171 | |
| Crinetics Pharmaceuticals, Inc. | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 199.542 $ | 0,30 | 5.613 | |
| Acadia Pharmaceuticals Inc. | Acadia Pharmaceuticals Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 198.059 $ | 0,29 | 9.144 | |
| Veracyte, Inc. | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 197.408 $ | 0,29 | 4.260 | |
| Edgewise Therapeutics, Inc. | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 196.454 $ | 0,29 | 5.751 | |
| Beam Therapeutics Inc. | Beam Therapeutics Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 179.831 $ | 0,27 | 5.461 | |
| Denali Therapeutics Inc. | Denali Therapeutics Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 178.882 $ | 0,27 | 8.502 | |
| 10x Genomics, Inc. | 10x Genomics, Inc., Class A | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 178.576 $ | 0,27 | 6.309 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 170.626 $ | 0,25 | 8.827 | |
| Structure Therapeutics Inc. | Structure Therapeutics Inc., ADR | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 164.284 $ | 0,24 | 4.176 | |
| Tango Therapeutics Inc. | Tango Therapeutics Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 158.696 $ | 0,24 | 7.220 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 151.885 $ | 0,23 | 2.595 | |
| GRAIL, Inc. | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 150.098 $ | 0,22 | 2.094 | |
| Alumis Inc. | Alumis Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 146.405 $ | 0,22 | 6.778 | |
| Arcutis Biotherapeutics, Inc. | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 142.709 $ | 0,21 | 6.650 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 142.340 $ | 0,21 | 2.046 | |
| Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 141.957 $ | 0,21 | 3.074 | |
| IDEAYA Biosciences, Inc. | IDEAYA Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 138.745 $ | 0,21 | 4.708 | |
| Vera Therapeutics, Inc. | Vera Therapeutics, Inc. | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 135.864 $ | 0,20 | 3.825 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 135.551 $ | 0,20 | 2.282 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 134.627 $ | 0,20 | 9.582 | |
| Mineralys Therapeutics, Inc. | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 133.655 $ | 0,20 | 4.243 | |
| Definium Therapeutics, Inc. | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 129.296 $ | 0,19 | 5.345 | |
| Enliven Therapeutics, Inc. | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 125.912 $ | 0,19 | 3.182 | |
| Adaptive Biotechnologies Corp. | Adaptive Biotechnologies Corp. | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 125.063 $ | 0,19 | 8.255 | |
| Ultragenyx Pharmaceutical Inc. | Ultragenyx Pharmaceutical Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 124.009 $ | 0,18 | 5.180 | |
| Legend Biotech Corp. | Legend Biotech Corp., ADR | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 122.899 $ | 0,18 | 4.525 | |
| Kodiak Sciences Inc. | Kodiak Sciences Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 120.152 $ | 0,18 | 3.273 | |
| BioCryst Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 119.804 $ | 0,18 | 13.446 | |
| Kiniksa Pharmaceuticals International, PLC | Kiniksa Pharmaceuticals International, PLC | EC | G52694109 | Long | Börsenkurs (Stufe 1) | 119.063 $ | 0,18 | 2.461 | |
| Aurinia Pharmaceuticals Inc. | Aurinia Pharmaceuticals Inc. | EC | 05156V102 | Long | Börsenkurs (Stufe 1) | 109.288 $ | 0,16 | 7.129 | |
| Ocular Therapeutix, Inc. | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 105.156 $ | 0,16 | 11.671 | |
| Pharvaris N.V. | Pharvaris N.V. | EC | N69605108 | Long | Börsenkurs (Stufe 1) | 103.841 $ | 0,15 | 3.443 | |
| NovoCure Ltd. | NovoCure Ltd. | EC | G6674U108 | Long | Börsenkurs (Stufe 1) | 103.467 $ | 0,15 | 6.072 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 102.468 $ | 0,15 | 2.393 | |
| ADMA Biologics, Inc. | ADMA Biologics, Inc. | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 101.889 $ | 0,15 | 12.768 | |
| Rapport Therapeutics, Inc. | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 101.673 $ | 0,15 | 2.574 | |
| AbCellera Biologics Inc. | AbCellera Biologics Inc. | EC | 00288U106 | Long | Börsenkurs (Stufe 1) | 100.281 $ | 0,15 | 16.253 | |
| Zymeworks Inc. | Zymeworks Inc. | EC | 98985Y108 | Long | Börsenkurs (Stufe 1) | 100.244 $ | 0,15 | 3.989 | |
| Sarepta Therapeutics, Inc. | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 99.840 $ | 0,15 | 5.587 | |
| Recursion Pharmaceuticals, Inc. | Recursion Pharmaceuticals, Inc., Class A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 99.824 $ | 0,15 | 27.806 | |
| Nurix Therapeutics, Inc. | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 97.414 $ | 0,14 | 5.485 | |
| Harmony Biosciences Holdings, Inc. | Harmony Biosciences Holdings, Inc. | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 97.392 $ | 0,14 | 3.083 | |
| Trevi Therapeutics, Inc. | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 96.576 $ | 0,14 | 6.830 | |
| Novavax, Inc. | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 95.823 $ | 0,14 | 8.735 | |
| Tyra Biosciences, Inc. | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 95.586 $ | 0,14 | 2.861 | |
| uniQure N.V. | uniQure N.V. | EC | N90064101 | Long | Börsenkurs (Stufe 1) | 95.290 $ | 0,14 | 3.340 | |
| Stoke Therapeutics, Inc. | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 95.203 $ | 0,14 | 3.080 | |
| ANI Pharmaceuticals, Inc. | ANI Pharmaceuticals, Inc. | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 94.369 $ | 0,14 | 1.202 | |
| Syndax Pharmaceuticals, Inc. | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 92.641 $ | 0,14 | 4.729 | |
| Agios Pharmaceuticals, Inc. | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 91.728 $ | 0,14 | 3.120 | |
| Genmab A/S | Genmab A/S, ADR | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 90.391 $ | 0,13 | 3.433 | |
| Iovance Biotherapeutics, Inc. | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 90.216 $ | 0,13 | 22.004 | |
| Vericel Corp. | Vericel Corp. | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 90.091 $ | 0,13 | 2.703 | |
| Intellia Therapeutics, Inc. | Intellia Therapeutics, Inc. | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 88.430 $ | 0,13 | 6.285 | |
| AtaiBeckley Inc. | AtaiBeckley Inc. | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 87.687 $ | 0,13 | 19.357 | |
| Taysha Gene Therapies Inc. | Taysha Gene Therapies Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 85.743 $ | 0,13 | 14.607 | |
| Innoviva, Inc. | Innoviva, Inc. | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 85.059 $ | 0,13 | 3.971 | |
| Amylyx Pharmaceuticals, Inc. | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 84.765 $ | 0,13 | 5.907 | |
| AnaptysBio, Inc. | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 82.614 $ | 0,12 | 1.484 | |
| Precigen, Inc. | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 82.039 $ | 0,12 | 18.903 | |
| Inhibrx Biosciences, Inc. | Inhibrx Biosciences, Inc. | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 80.816 $ | 0,12 | 777 | |
| Monte Rosa Therapeutics, Inc. | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 80.101 $ | 0,12 | 4.064 | |
| Vir Biotechnology, Inc. | Vir Biotechnology, Inc. | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 79.888 $ | 0,12 | 8.374 | |
| Ardelyx, Inc. | Ardelyx, Inc. | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 79.873 $ | 0,12 | 13.224 | |
| GH Research PLC | GH Research PLC | EC | G3855L106 | Long | Börsenkurs (Stufe 1) | 79.767 $ | 0,12 | 3.325 | |
| Fortrea Holdings Inc. | Fortrea Holdings Inc. | EC | 34965K107 | Long | Börsenkurs (Stufe 1) | 77.150 $ | 0,11 | 5.013 | |
| MBX Biosciences, Inc. | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 75.748 $ | 0,11 | 2.407 | |
| KalVista Pharmaceuticals, Inc. | KalVista Pharmaceuticals, Inc. | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 73.516 $ | 0,11 | 2.736 | |
| Bicara Therapeutics Inc. | Bicara Therapeutics Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 73.515 $ | 0,11 | 3.380 | |
| Septerna, Inc. | Septerna, Inc. | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 71.665 $ | 0,11 | 2.373 | |
| UroGen Pharma Ltd. | UroGen Pharma Ltd. | EC | M96088105 | Long | Börsenkurs (Stufe 1) | 70.578 $ | 0,10 | 2.509 | |
| Harrow, Inc. | Harrow, Inc. | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 69.364 $ | 0,10 | 1.970 | |
| Maze Therapeutics, Inc. | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 68.267 $ | 0,10 | 2.580 | |
| Immunocore Holdings PLC | Immunocore Holdings PLC, ADR | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 67.920 $ | 0,10 | 2.351 | |
| ArriVent Biopharma, Inc. | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 66.624 $ | 0,10 | 2.201 | |
| Wave Life Sciences Ltd. | Wave Life Sciences Ltd. | EC | Y95308105 | Long | Börsenkurs (Stufe 1) | 66.412 $ | 0,10 | 10.093 | |
| COMPASS Pathways PLC | COMPASS Pathways PLC, ADR | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 66.031 $ | 0,10 | 5.056 | |
| Personalis, Inc. | Personalis, Inc. | EC | 71535D106 | Long | Börsenkurs (Stufe 1) | 63.031 $ | 0,09 | 5.529 | |
| MannKind Corp. | MannKind Corp. | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 62.273 $ | 0,09 | 16.518 | |
| EyePoint, Inc. | EyePoint, Inc. | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 60.268 $ | 0,09 | 4.438 | |
| Alvotech | Alvotech | EC | L01800108 | Long | Börsenkurs (Stufe 1) | 59.496 $ | 0,09 | 17.707 | |
| Savara Inc. | Savara Inc. | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 56.722 $ | 0,08 | 10.908 | |
| Collegium Pharmaceutical, Inc. | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 56.633 $ | 0,08 | 1.685 | |
| Olema Pharmaceuticals, Inc. | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 56.466 $ | 0,08 | 4.281 | |
| Corvus Pharmaceuticals, Inc. | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 54.939 $ | 0,08 | 4.427 | |
| Xeris Biopharma Holdings, Inc. | Xeris Biopharma Holdings, Inc. | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 54.793 $ | 0,08 | 8.895 | |
| AbSci Corp. | AbSci Corp. | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 54.716 $ | 0,08 | 8.106 | |
| Zenas Biopharma, Inc. | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 52.955 $ | 0,08 | 2.878 | |
| Cullinan Therapeutics, Inc. | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 52.065 $ | 0,08 | 3.167 | |
| Grifols, S.A. | Grifols, S.A., ADR | EC | 398438408 | Long | Börsenkurs (Stufe 1) | 51.339 $ | 0,08 | 6.540 | |
| Pacira Biosciences, Inc. | Pacira Biosciences, Inc. | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 49.853 $ | 0,07 | 2.147 | |
| ARS Pharmaceuticals, Inc. | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 48.352 $ | 0,07 | 5.331 | |
| Sana Biotechnology, Inc. | Sana Biotechnology, Inc. | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 47.421 $ | 0,07 | 14.370 | |
| Arbutus Biopharma Corp. | Arbutus Biopharma Corp. | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 47.018 $ | 0,07 | 10.311 | |
| Kura Oncology, Inc. | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 46.889 $ | 0,07 | 4.597 | |
| Janux Therapeutics, Inc. | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 46.878 $ | 0,07 | 3.213 | |
| Xencor, Inc. | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 46.712 $ | 0,07 | 3.932 | |
| MeiraGTx Holdings PLC | MeiraGTx Holdings PLC | EC | G59665102 | Long | Börsenkurs (Stufe 1) | 45.955 $ | 0,07 | 4.315 | |
| Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals, Inc. | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 45.806 $ | 0,07 | 2.430 | |
| ORIC Pharmaceuticals, Inc. | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 44.819 $ | 0,07 | 5.304 | |
| Theravance Biopharma Inc. | Theravance Biopharma Inc. | EC | G8807B106 | Long | Börsenkurs (Stufe 1) | 43.635 $ | 0,06 | 2.717 | |
| Eton Pharmaceuticals, Inc. | Eton Pharmaceuticals, Inc. | EC | 29772L108 | Long | Börsenkurs (Stufe 1) | 43.269 $ | 0,06 | 1.421 | |
| Geron Corp. | Geron Corp. | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 42.779 $ | 0,06 | 34.223 | |
| Mesoblast Ltd. | Mesoblast Ltd., ADR | EC | 590717401 | Long | Börsenkurs (Stufe 1) | 42.612 $ | 0,06 | 2.767 | |
| Annexon, Inc. | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 42.319 $ | 0,06 | 7.808 | |
| Omeros Corp. | Omeros Corp. | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 41.963 $ | 0,06 | 3.801 | |
| Phathom Pharmaceuticals, Inc. | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 40.719 $ | 0,06 | 4.246 | |
| BioAge Labs, Inc. | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 39.663 $ | 0,06 | 2.294 | |
| Esperion Therapeutics, Inc. | Esperion Therapeutics, Inc. | EC | 29664W105 | Long | Börsenkurs (Stufe 1) | 39.447 $ | 0,06 | 12.603 | |
| Replimune Group, Inc. | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 37.906 $ | 0,06 | 4.362 | |
| Maravai LifeSciences Holdings, Inc. | Maravai LifeSciences Holdings, Inc., Class A | EC | 56600D107 | Long | Börsenkurs (Stufe 1) | 37.080 $ | 0,06 | 7.725 | |
| CorMedix Inc. | CorMedix Inc. | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 35.153 $ | 0,05 | 4.165 | |
| Zevra Therapeutics, Inc. | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 34.457 $ | 0,05 | 2.973 | |
| Phibro Animal Health Corp. | Phibro Animal Health Corp., Class A | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 33.931 $ | 0,05 | 1.102 | |
| Prime Medicine, Inc. | Prime Medicine, Inc. | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 33.810 $ | 0,05 | 9.524 | |
| Vor BioPharma Inc. | Vor BioPharma Inc. | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 33.578 $ | 0,05 | 2.243 | |
| Castle Biosciences, Inc. | Castle Biosciences, Inc. | EC | 14843C105 | Long | Börsenkurs (Stufe 1) | 33.011 $ | 0,05 | 1.566 | |
| CytomX Therapeutics, Inc. | CytomX Therapeutics, Inc. | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 32.148 $ | 0,05 | 8.930 | |
| Candel Therapeutics, Inc. | Candel Therapeutics, Inc. | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 32.088 $ | 0,05 | 3.866 | |
| Zai Lab Ltd. | Zai Lab Ltd., ADR | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 32.001 $ | 0,05 | 1.809 | |
| Design Therapeutics, Inc. | Design Therapeutics, Inc. | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 31.566 $ | 0,05 | 3.012 | |
| Tectonic Therapeutic, Inc. | Tectonic Therapeutic, Inc. | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 31.165 $ | 0,05 | 1.000 | |
| Ironwood Pharmaceuticals, Inc. | Ironwood Pharmaceuticals, Inc. | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 30.706 $ | 0,05 | 8.601 | |
| Arvinas, Inc. | Arvinas, Inc. | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 30.272 $ | 0,04 | 3.371 | |
| Solid Biosciences Inc. | Solid Biosciences Inc. | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 30.197 $ | 0,04 | 4.114 | |
| Rigel Pharmaceuticals, Inc. | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 29.362 $ | 0,04 | 963 | |
| Aclaris Therapeutics, Inc. | Aclaris Therapeutics, Inc. | EC | 00461U105 | Long | Börsenkurs (Stufe 1) | 28.956 $ | 0,04 | 6.364 | |
| Prothena Corp. PLC | Prothena Corp. PLC | EC | G72800108 | Long | Börsenkurs (Stufe 1) | 28.789 $ | 0,04 | 2.828 | |
| 4D Molecular Therapeutics, Inc. | 4D Molecular Therapeutics, Inc. | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 26.638 $ | 0,04 | 2.688 | |
| Aquestive Therapeutics, Inc. | Aquestive Therapeutics, Inc. | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 25.893 $ | 0,04 | 6.441 | |
| Kyverna Therapeutics, Inc. | Kyverna Therapeutics, Inc. | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 25.747 $ | 0,04 | 3.022 | |
| Allogene Therapeutics, Inc. | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 25.745 $ | 0,04 | 11.864 | |
| Aura Biosciences, Inc. | Aura Biosciences, Inc. | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 24.987 $ | 0,04 | 3.345 | |
| Fulcrum Therapeutics, Inc. | Fulcrum Therapeutics, Inc. | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 24.227 $ | 0,04 | 3.501 | |
| Kamada Ltd. | Kamada Ltd. | EC | M6240T109 | Long | Börsenkurs (Stufe 1) | 23.852 $ | 0,04 | 3.054 | |
| Neurogene Inc. | Neurogene Inc. | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 23.777 $ | 0,04 | 839 | |
| Upstream Bio, Inc. | Upstream Bio, Inc. | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 23.742 $ | 0,04 | 2.840 | |
| Pacific Biosciences of California, Inc. | Pacific Biosciences of California, Inc. | EC | 69404D108 | Long | Börsenkurs (Stufe 1) | 23.742 $ | 0,04 | 15.934 | |
| First Tracks Biotherapeutics, Inc. | First Tracks Biotherapeutics, Inc. | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 23.493 $ | 0,03 | 1.472 | |
| Lakefront Biotherapeutics N.V. | Lakefront Biotherapeutics N.V., ADR | EC | 36315X101 | Long | Börsenkurs (Stufe 1) | 22.510 $ | 0,03 | 794 | |
| C4 Therapeutics, Inc. | C4 Therapeutics, Inc. | EC | 12529R107 | Long | Börsenkurs (Stufe 1) | 22.462 $ | 0,03 | 5.140 | |
| Evolus, Inc. | Evolus, Inc. | EC | 30052C107 | Long | Börsenkurs (Stufe 1) | 22.448 $ | 0,03 | 3.422 | |
| Contineum Therapeutics, Inc. | Contineum Therapeutics, Inc., Class A | EC | 21217B100 | Long | Börsenkurs (Stufe 1) | 21.692 $ | 0,03 | 1.608 | |
| OmniAb, Inc. | OmniAb, Inc. | EC | 68218J103 | Long | Börsenkurs (Stufe 1) | 20.471 $ | 0,03 | 7.832 | |
| Altimmune, Inc. | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 20.164 $ | 0,03 | 6.611 | |
| Vanda Pharmaceuticals Inc. | Vanda Pharmaceuticals Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 20.072 $ | 0,03 | 3.112 | |
| Enanta Pharmaceuticals, Inc. | Enanta Pharmaceuticals, Inc. | EC | 29251M106 | Long | Börsenkurs (Stufe 1) | 20.069 $ | 0,03 | 1.525 | |
| Larimar Therapeutics, Inc. | Larimar Therapeutics, Inc. | EC | 517125100 | Long | Börsenkurs (Stufe 1) | 19.961 $ | 0,03 | 5.736 | |
| Lexeo Therapeutics, Inc. | Lexeo Therapeutics, Inc. | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 19.789 $ | 0,03 | 3.850 | |
| Autolus Therapeutics PLC | Autolus Therapeutics PLC, ADR | EC | 05280R100 | Long | Börsenkurs (Stufe 1) | 19.775 $ | 0,03 | 10.575 | |
| Immuneering Corp. | Immuneering Corp., Class A | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 19.658 $ | 0,03 | 3.407 | |
| Lyell Immunopharma, Inc. | Lyell Immunopharma, Inc. | EC | 55083R203 | Long | Börsenkurs (Stufe 1) | 19.392 $ | 0,03 | 1.119 | |
| Atea Pharmaceuticals, Inc. | Atea Pharmaceuticals, Inc. | EC | 04683R106 | Long | Börsenkurs (Stufe 1) | 19.273 $ | 0,03 | 4.127 | |
| Puma Biotechnology, Inc. | Puma Biotechnology, Inc. | EC | 74587V107 | Long | Börsenkurs (Stufe 1) | 19.216 $ | 0,03 | 2.680 | |
| Cabaletta Bio, Inc. | Cabaletta Bio, Inc. | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 19.214 $ | 0,03 | 5.083 | |
| REGENXBIO Inc. | REGENXBIO Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 18.682 $ | 0,03 | 2.665 | |
| Keros Therapeutics, Inc. | Keros Therapeutics, Inc. | EC | 492327101 | Long | Börsenkurs (Stufe 1) | 18.113 $ | 0,03 | 1.610 | |
| Editas Medicine, Inc. | Editas Medicine, Inc. | EC | 28106W103 | Long | Börsenkurs (Stufe 1) | 17.795 $ | 0,03 | 5.143 | |
| SIGA Technologies, Inc. | SIGA Technologies, Inc. | EC | 826917106 | Long | Börsenkurs (Stufe 1) | 17.639 $ | 0,03 | 3.769 | |
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 17.606 $ | 0,03 | 5.735 | |
| Silence Therapeutics PLC | Silence Therapeutics PLC, ADR | EC | 82686Q101 | Long | Börsenkurs (Stufe 1) | 17.084 $ | 0,03 | 2.476 | |
| Invivyd, Inc. | Invivyd, Inc. | EC | 00534A102 | Long | Börsenkurs (Stufe 1) | 16.652 $ | 0,02 | 14.607 | |
| Neumora Therapeutics, Inc. | Neumora Therapeutics, Inc. | EC | 640979100 | Long | Börsenkurs (Stufe 1) | 16.302 $ | 0,02 | 8.812 | |
| Alpha Teknova, Inc. | Alpha Teknova, Inc. | EC | 02080L102 | Long | Börsenkurs (Stufe 1) | 15.250 $ | 0,02 | 2.824 | |
| Anavex Life Sciences Corp. | Anavex Life Sciences Corp. | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 14.780 $ | 0,02 | 4.878 | |
| Entrada Therapeutics, Inc. | Entrada Therapeutics, Inc. | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 14.260 $ | 0,02 | 2.017 | |
| AC Immune S.A. | AC Immune S.A. | EC | H00263105 | Long | Börsenkurs (Stufe 1) | 14.130 $ | 0,02 | 5.312 | |
| Humacyte, Inc. | Humacyte, Inc. | EC | 44486Q103 | Long | Börsenkurs (Stufe 1) | 13.234 $ | 0,02 | 10.180 | |
| Codexis, Inc. | Codexis, Inc. | EC | 192005106 | Long | Börsenkurs (Stufe 1) | 13.202 $ | 0,02 | 4.766 | |
| Foghorn Therapeutics Inc. | Foghorn Therapeutics Inc. | EC | 344174107 | Long | Börsenkurs (Stufe 1) | 13.187 $ | 0,02 | 3.081 | |
| LENZ Therapeutics, Inc. | LENZ Therapeutics, Inc. | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 12.899 $ | 0,02 | 1.658 | |
| Coherus Oncology, Inc. | Coherus Oncology, Inc. | EC | 19249H103 | Long | Börsenkurs (Stufe 1) | 12.529 $ | 0,02 | 7.880 | |
| Quantum-Si Inc. | Quantum-Si Inc. | EC | 74765K105 | Long | Börsenkurs (Stufe 1) | 12.262 $ | 0,02 | 10.304 | |
| Voyager Therapeutics, Inc. | Voyager Therapeutics, Inc. | EC | 92915B106 | Long | Börsenkurs (Stufe 1) | 12.005 $ | 0,02 | 3.102 | |
| Sagimet Biosciences Inc. | Sagimet Biosciences Inc., Class A | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 11.963 $ | 0,02 | 1.641 | |
| Arcturus Therapeutics Holdings Inc. | Arcturus Therapeutics Holdings Inc. | EC | 03969T109 | Long | Börsenkurs (Stufe 1) | 11.793 $ | 0,02 | 1.489 | |
| Orchestra Biomed Holdings, Inc. | Orchestra Biomed Holdings, Inc. | EC | 68572M106 | Long | Börsenkurs (Stufe 1) | 11.664 $ | 0,02 | 2.983 | |
| Caribou Biosciences, Inc. | Caribou Biosciences, Inc. | EC | 142038108 | Long | Börsenkurs (Stufe 1) | 11.623 $ | 0,02 | 4.925 | |
| Bicycle Therapeutics PLC | Bicycle Therapeutics PLC, ADR | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 11.439 $ | 0,02 | 2.439 | |
| NovaBridge Biosciences | NovaBridge Biosciences, ADR | EC | 44975P103 | Long | Börsenkurs (Stufe 1) | 10.902 $ | 0,02 | 5.925 | |
| Tenaya Therapeutics, Inc. | Tenaya Therapeutics, Inc. | EC | 87990A106 | Long | Börsenkurs (Stufe 1) | 9.925 $ | 0,01 | 11.421 | |
| Lifecore Biomedical, Inc. | Lifecore Biomedical, Inc. | EC | 514766104 | Long | Börsenkurs (Stufe 1) | 9.884 $ | 0,01 | 1.969 | |
| Jyong Biotech Ltd. | Jyong Biotech Ltd. | EC | G83116106 | Long | Börsenkurs (Stufe 1) | 8.633 $ | 0,01 | 3.924 | |
| Black Diamond Therapeutics, Inc. | Black Diamond Therapeutics, Inc. | EC | 09203E105 | Long | Börsenkurs (Stufe 1) | 6.689 $ | 0,01 | 3.013 | |
| Pyxis Oncology, Inc. | Pyxis Oncology, Inc. | EC | 747324101 | Long | Börsenkurs (Stufe 1) | 5.900 $ | 0,01 | 3.278 | |
| PepGen Inc. | PepGen Inc. | EC | 713317105 | Long | Börsenkurs (Stufe 1) | 5.441 $ | 0,01 | 3.627 | |
| Rani Therapeutics Holdings, Inc. | Rani Therapeutics Holdings, Inc., Class A | EC | 753018100 | Long | Börsenkurs (Stufe 1) | 4.886 $ | 0,01 | 5.139 | |
| Aardvark Therapeutics, Inc. | Aardvark Therapeutics, Inc. | EC | 002942100 | Long | Börsenkurs (Stufe 1) | 4.727 $ | 0,01 | 1.150 | |
| Gossamer Bio, Inc. | Gossamer Bio, Inc. | EC | 38341P102 | Long | Börsenkurs (Stufe 1) | 2.819 $ | 0,00 | 12.208 | |
| Cartesian Therapeutics, Inc. | Cartesian Therapeutics, Inc., Rts., 2050-12-31 | EC | 816212112 | Long | Schätzwert (Stufe 3) | 359 $ | 0,00 | 2.633 | |
| Third Harmonic Bio, Inc. | Third Harmonic Bio, Inc., Class B | EC | 88427A107 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 1.605 | |
| Novo Nordisk A/S | Novo Nordisk A/S | EC | 009CVR044 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 3.794 | |
| 67.285.966 $ | 99,87 | 1.726.013 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
SEC-Meldungen und stellen keine Bewertung oder Empfehlung zu einzelnen Wertpapieren,
Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher SEC-Meldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.